Aspergillus-associated airway disease, inflammation, and the innate immune response
- PMID: 23971044
- PMCID: PMC3736487
- DOI: 10.1155/2013/723129
Aspergillus-associated airway disease, inflammation, and the innate immune response
Abstract
Aspergillus moulds exist ubiquitously as spores that are inhaled in large numbers daily. Whilst most are removed by anatomical barriers, disease may occur in certain circumstances. Depending on the underlying state of the human immune system, clinical consequences can ensue ranging from an excessive immune response during allergic bronchopulmonary aspergillosis to the formation of an aspergilloma in the immunocompetent state. The severest infections occur in those who are immunocompromised where invasive pulmonary aspergillosis results in high mortality rates. The diagnosis of Aspergillus-associated pulmonary disease is based on clinical, radiological, and immunological testing. An understanding of the innate and inflammatory consequences of exposure to Aspergillus species is critical in accounting for disease manifestations and preventing sequelae. The major components of the innate immune system involved in recognition and removal of the fungus include phagocytosis, antimicrobial peptide production, and recognition by pattern recognition receptors. The cytokine response is also critical facilitating cell-to-cell communication and promoting the initiation, maintenance, and resolution of the host response. In the following review, we discuss the above areas with a focus on the innate and inflammatory response to airway Aspergillus exposure and how these responses may be modulated for therapeutic benefit.
Figures
Similar articles
-
The innate immune response to Aspergillus fumigatus.Microbes Infect. 2009 Oct;11(12):919-27. doi: 10.1016/j.micinf.2009.07.002. Epub 2009 Jul 15. Microbes Infect. 2009. PMID: 19615460 Review.
-
Aspergillus in chronic lung disease: Modeling what goes on in the airways.Med Mycol. 2017 Jan 1;55(1):39-47. doi: 10.1093/mmy/myw117. Epub 2016 Nov 12. Med Mycol. 2017. PMID: 27838644 Review.
-
Bronchial Epithelial Cells on the Front Line to Fight Lung Infection-Causing Aspergillus fumigatus.Front Immunol. 2020 May 22;11:1041. doi: 10.3389/fimmu.2020.01041. eCollection 2020. Front Immunol. 2020. PMID: 32528481 Free PMC article. Review.
-
H-ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses.Immunology. 2015 Oct;146(2):281-91. doi: 10.1111/imm.12501. Epub 2015 Aug 24. Immunology. 2015. PMID: 26133042 Free PMC article.
-
Characterisation of innate fungal recognition in the lung.PLoS One. 2012;7(4):e35675. doi: 10.1371/journal.pone.0035675. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536422 Free PMC article.
Cited by
-
Accelerating the understanding of Aspergillus terreus: Epidemiology, physiology, immunology and advances.Curr Res Microb Sci. 2024 Jan 11;6:100220. doi: 10.1016/j.crmicr.2024.100220. eCollection 2024. Curr Res Microb Sci. 2024. PMID: 38303967 Free PMC article. Review.
-
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD.Eur Respir J. 2020 Aug 27;56(2):2000418. doi: 10.1183/13993003.00418-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32341102 Free PMC article.
-
Hot topics and current controversies in non-cystic fibrosis bronchiectasis.Breathe (Sheff). 2019 Dec;15(4):286-295. doi: 10.1183/20734735.0261-2019. Breathe (Sheff). 2019. PMID: 31803263 Free PMC article. Review.
-
Evaluation of Droplet Digital Polymerase Chain Reaction (ddPCR) for the Absolute Quantification of Aspergillus species in the Human Airway.Int J Mol Sci. 2020 Apr 26;21(9):3043. doi: 10.3390/ijms21093043. Int J Mol Sci. 2020. PMID: 32357408 Free PMC article.
-
Upper respiratory tract mycobiome alterations in different kinds of pulmonary disease.Front Microbiol. 2023 Mar 23;14:1117779. doi: 10.3389/fmicb.2023.1117779. eCollection 2023. Front Microbiol. 2023. PMID: 37032908 Free PMC article.
References
-
- Bardana EJ., Jr. The clinical spectrum of aspergillosis—part 1: epidemiology, pathogenicity, infection in animals and immunology of Aspergillus. Critical Reviews in Clinical Laboratory Sciences. 1981;13(1):21–83. - PubMed
-
- Greenberger PA. Allergic bronchopulmonary aspergillosis. Journal of Allergy and Clinical Immunology. 2002;110(5):685–692. - PubMed
-
- Greenberger PA. Clinical aspects of allergic bronchopulmonary aspergillosis. Frontiers in Bioscience. 2003;8:s119–s127. - PubMed
-
- Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Frontiers in Bioscience. 2003;8:e190–e196. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical